Sertoli-Leydig cell tumour

(redirected from Sertoli-Leydig tumor)

Sertoli-Leydig cell tumour

A sex-cord/stromal tumour affecting both the testis and ovaries, which is characterised by a mixed population of Sertoli and Leydig cells, of which the Leydig cells produce and secrete testosterone, causing virilisation.
 
DiffDx
Adenocarcinoma.

Molecular pathology
Some cases are linked a mutation on DICER1, a gene on chromosome 14q32.13 which encodes a protein that acts as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component which represses gene expression. DICER1 cases occur in younger patients with multinodular goiter, and have an increased risk of primitive tumours—e.g., pleuropulmonary blastoma, Wilms tumor and rhabdomyosarcoma of the cervix.

Management
Conservative surgery, especially in young women.

Prognosis
Generally good; clinical malignancy develops in ±20%.
References in periodicals archive ?
Sertoli-Leydig tumors of the ovary: a clinicopathologic study of 64 intermediate and poorly differentiated neoplasms Am J Surg path 1984:8(6)
They found that 69% of granulosa cell tumors and 67% of Sertoli-Leydig tumors expressed the MIC2 (O13) antibody in a membranous fashion, while less than 25% of the carcinomas and 0% of other sex cord-stromal tumors expressed MIC2 (O13) antibody.
The most frequently seen stromal tumors are granulosa cell tumors and Sertoli-Leydig tumors, which develop in granulosa cells and Sertoli-Leydig cells found in the stroma.